Last 12 months
Inside the activity.
1 purchase rows · 62 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 20 |
| Jan 2026 | 1 | 20 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2022 Filed Apr 22, 2022 15:18 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 132,891 | $3.01 | $400,001.91 |
DisclosureSEC source: 0001308627-22-000002 · primary_doc.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,742,030 Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 12:48 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 132,891 | $3.01 | $400,001.91 |
DisclosureSEC source: 0001562180-22-003501 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,844,288 F1 · shares: Mr. Matlin purchased 132,891 shares of common stock of Clene Inc. on April 20, 2022 for a purchase price of $3.01 per share. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 12:56 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 8,648 | $3.23 | $27,933.04 |
DisclosureSEC source: 0001562180-22-002993 · primarydocument.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,711,397 F2 · price: Mr. Matlin purchased 8,648 shares of common stock of Clene Inc. in multiple transactions on March 29, 2022 at prices ranging from $3.20 to $3.28, inclusive, for a weighted average price of $3.23 per share. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 12:56 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 10,000 | $3.10 | $31,000.00 |
DisclosureSEC source: 0001562180-22-002993 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,702,749 F1 · price: Mr. Matlin purchased 10,000 shares of common stock of Clene Inc. in multiple transactions on March 28, 2022 at prices ranging from $2.97 to $3.22, inclusive, for a weighted average price of $3.10 per share. Read SEC document |
| March 24, 2022 Filed Mar 25, 2022 13:32 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 20,000 | $2.99 | $59,800.00 |
DisclosureSEC source: 0001562180-22-002945 · primarydocument.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,692,749 F2 · price: Mr. Matlin purchased 20,000 shares of common stock of Clene Inc. in multiple transactions on March 24, 2022 at prices ranging from $2.91 to $3.05, inclusive, for a weighted average price of $2.99 per share. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 13:32 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 20,000 | $2.94 | $58,800.00 |
DisclosureSEC source: 0001562180-22-002945 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,672,749 F1 · price: Mr. Matlin purchased 20,000 shares of common stock of Clene Inc. in multiple transactions on March 23, 2022 at prices ranging from $2.85 to $3.01, inclusive, for a weighted average price of $2.94 per share. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 14:06 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 35,000 | $2.90 | $101,500.00 |
DisclosureSEC source: 0001562180-22-002861 · primarydocument.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652,749 F2 · price: Mr. Matlin purchased 35,000 shares of common stock of Clene Inc. in multiple transactions on March 21, 2022 at prices ranging from $2.73 to $3.07, inclusive, for a weighted average price of $2.90 per share. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 14:06 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 20,000 | $2.79 | $55,800.00 |
DisclosureSEC source: 0001562180-22-002861 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,617,749 F1 · price: Mr. Matlin purchased 20,000 shares of common stock of Clene Inc. in multiple transactions on March 18, 2022 at prices ranging from $2.64 to $2.90, inclusive, for a weighted average price of $2.79 per share. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 20:31 UTC |
Stevens John HenryDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 273,194 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001562180-22-001623 · primarydocument.xml · derivative · entry 3 Stevens John Henry · CIK 0001835543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 273,194 shares Expires 2025-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 20:31 UTC |
Stevens John HenryDirector
|
Exercise / conversionCommon Stock | 273,194 | $0.53 | $144,792.82 |
DisclosureSEC source: 0001562180-22-001623 · primarydocument.xml · nonDerivative · entry 1 Stevens John Henry · CIK 0001835543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 14:07 UTC |
Mortenson MarkChief Science Officer
|
GrantStock Options (Right to buy) · Derivative | 200,000 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001562180-22-001502 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: This option was granted on February 15, 2022 as an option for 200,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month beginning March 15, 2023 until such shares are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 09:02 UTC |
Glanzman RobertChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 140,000 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001562180-22-001501 · primarydocument.xml · derivative · entry 1 Glanzman Robert · CIK 0001835428 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: This option was granted on February 15, 2022 as an option for 140,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month thereafter beginning March 15, 2023 until such shares are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 13:59 UTC |
Etherington Robert DeeDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 480,000 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001562180-22-001500 · primarydocument.xml · derivative · entry 2 Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,000 Underlying: Common Stock · 480,000 shares Expires 2032-02-15 F2 · derivative.exercise_date: This option was granted on February 15, 2022 as an option for 480,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month thereafter beginning March 15, 2023 until such shares are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 13:59 UTC |
Etherington Robert DeeDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 69,652 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001562180-22-001500 · primarydocument.xml · derivative · entry 1 Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,652 Underlying: Common Stock · 69,652 shares Expires 2032-02-15 F1 · derivative.exercise_date: This option was granted on February 15, 2022 as an option for 69,652 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options shall vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:35 UTC |
McLaughlin VallerieDirector
|
GrantStock Options (Right to buy) · Derivative | 5,473 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001120 · primarydocument.xml · derivative · entry 1 McLaughlin Vallerie · CIK 0001876030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,473 Underlying: Common Stock · 5,473 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 5,473 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:34 UTC |
Gay JonathonDirector
|
GrantStock Options (Right to buy) · Derivative | 5,473 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001117 · primarydocument.xml · derivative · entry 1 Gay Jonathon · CIK 0001835422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,473 Underlying: Common Stock · 5,473 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 5,473 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:35 UTC |
MATLIN DAVID JDirector
|
GrantStock Options (Right to buy) · Derivative | 9,701 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001119 · primarydocument.xml · derivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,701 Underlying: Common Stock · 9.701 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 9,701 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:37 UTC |
Ugwumba ChidozieDirector
|
GrantStock Options (Right to buy) · Derivative | 5.908 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001123 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5.908 Underlying: Common Stock · 5,908 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 5,908 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:36 UTC |
Stevens John HenryDirector
|
GrantStock Options (Right to buy) · Derivative | 6,219 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001122 · primarydocument.xml · derivative · entry 1 Stevens John Henry · CIK 0001835543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Underlying: Common Stock · 6,219 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 2, 2022 as an option for 6,219 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:36 UTC |
Mosca AlisonDirector
|
GrantStock Options (Right to buy) · Derivative | 7,587 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001121 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,587 Underlying: Common Stock · 7,587 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 7,587 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:35 UTC |
Jacobovitz ShalomDirector
|
GrantStock Options (Right to buy) · Derivative | 7,400 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001118 · primarydocument.xml · derivative · entry 1 Jacobovitz Shalom · CIK 0001835556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,400 Underlying: Common Stock · 7,400 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 7,400 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 03, 2022 Filed Feb 15, 2022 21:58 UTC Amendment |
Stevens John HenryDirector
|
GrantStock Options (Right to buy) · Derivative | 5,721 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001481 · primarydocument.xml · derivative · entry 1 Stevens John Henry · CIK 0001835543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,721 Underlying: Common Stock · 5,721 shares Expires 2032-02-03 F1 · shares: This Form 4 amendment is being filed to correct a Form 4 filed on February 4, 2022. The corrected date of the grant is February 3, 2022 and the corrected number of options granted is 5,721. F2 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 5,721 shares of Common Stock under the Clene 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 20:08 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 101,352 | $2.96 | $300,001.92 |
DisclosureSEC source: 0001562180-22-000901 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,597,749 F1 · shares: Mr. Matlin purchased 101,352 shares of common stock of Clene Inc. on February 1, 2022 for a purchase price of $2.96 per share. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:15 UTC |
BROWN MORGAN RChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 250,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001562180-22-001004 · primarydocument.xml · derivative · entry 1 BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: This option was granted on February 1, 2022 as an option for 250,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.96 per share. The options vest with respect to the first 25% of such shares on February 1, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month, beginning February 1, 2023, until such shares are fully vested Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 15:17 UTC |
General Resonance LLC10% owner
|
SaleCommon Stock | 101,352 | $2.96 | $300,001.92 |
DisclosureSEC source: 0001308627-22-000001 · primary_doc.xml · nonDerivative · entry 1 General Resonance LLC · CIK 0001308627 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,874,921 Read SEC document |
| January 20, 2022 Filed Jan 20, 2022 22:02 UTC |
WILCOX REED NDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 253,000 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001562180-22-000549 · primarydocument.xml · derivative · entry 2 WILCOX REED N · CIK 0001266609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,911 Underlying: Common Stock · 253,000 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2022 Filed Jan 20, 2022 22:02 UTC |
WILCOX REED NDirector
|
Exercise / conversionCommon Stock | 253,000 | $0.15 | $37,950.00 |
DisclosureSEC source: 0001562180-22-000549 · primarydocument.xml · nonDerivative · entry 1 WILCOX REED N · CIK 0001266609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2021 Filed Feb 22, 2022 21:56 UTC |
Ugwumba ChidozieDirector
|
OtherCommon Stock | 4,528,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-22-000063 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis II, LLC Disclosed balance after: 4,528,809 F1 · kind: The shares are directly held by SymBiosis II, LLC. Previously, the beneficial owner of these shares was Thomas Layton Walton, by virtue of his sole voting power and dispositive power through SymBiosis II, LLC. Although SymBiosis II, LLC continues to hold these shares directly and Thomas Layton Walton continues to hold his pecuniary interest in these shares, the reporting person now exercises sole voting power and dispositive power through SymBiosis II, LLC through a transition of that power to the reporting person (and not through a sale or other transfer of these shares). Read SEC document |
| December 10, 2021 Filed Dec 10, 2021 19:55 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 15,000 | $4.87 | $73,050.00 |
DisclosureSEC source: 0001562180-21-007620 · primarydocument.xml · nonDerivative · entry 3 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,496,397 F3 · price: Mr. Matlin purchased 15,000 shares of common stock of Clene Inc. in multiple transactions on December 10, 2021 at prices ranging from $4.77 to $4.94, inclusive, for a weighted average price of $4.87 per share. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 19:55 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001562180-21-007620 · primarydocument.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481,397 F2 · price: Mr. Matlin purchased 40,000 shares of common stock of Clene Inc. in multiple transactions on December 9, 2021 at prices ranging from $4.90 to $5.10, inclusive, for a weighted average price of $5.00 per share. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 19:55 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 5,000 | $4.93 | $24,650.00 |
DisclosureSEC source: 0001562180-21-007620 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441,397 F1 · price: Mr. Matlin purchased 5,000 shares of common stock of Clene Inc. in multiple transactions on December 8, 2021 at prices ranging from $4.91 to $4.95, inclusive, for a weighted average price of $4.93 per share. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 17:17 UTC |
MATLIN DAVID JDirector
|
OtherWarrants (Right to buy) · Derivative | 50,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001562180-21-007553 · primarydocument.xml · derivative · entry 4 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2021-12-31 F2 · shares: The Matlin Family Trust 2020 exercised its warrant right and acquired 50,000 shares of common stock of Clene Inc for $0.01 per share. F3 · ownership.nature: The securities are owned by the Matlin Family Trust 2020. Mr. Matlin is the trustee of the Matlin Family Trust 2020. The shares owned by the Matlin Family Trust 2020 may be deemed to be beneficially owned by Mr. Matlin. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 17:17 UTC |
MATLIN DAVID JDirector
|
OtherWarrants (Right to buy) · Derivative | 12,500 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001562180-21-007553 · primarydocument.xml · derivative · entry 3 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2021-12-31 F1 · shares: Mr. Matlin exercised his warrant right and acquired 12,500 shares of common stock of Clene Inc for $0.01 per share. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 17:17 UTC |
MATLIN DAVID JDirector
|
OtherCommon Stock | 50,000 | $0.01 | $500.00 |
DisclosureSEC source: 0001562180-21-007553 · primarydocument.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 150,000 F2 · shares: The Matlin Family Trust 2020 exercised its warrant right and acquired 50,000 shares of common stock of Clene Inc for $0.01 per share. F3 · ownership.nature: The securities are owned by the Matlin Family Trust 2020. Mr. Matlin is the trustee of the Matlin Family Trust 2020. The shares owned by the Matlin Family Trust 2020 may be deemed to be beneficially owned by Mr. Matlin. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 17:17 UTC |
MATLIN DAVID JDirector
|
OtherCommon Stock | 12,500 | $0.01 | $125.00 |
DisclosureSEC source: 0001562180-21-007553 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,436,397 F1 · shares: Mr. Matlin exercised his warrant right and acquired 12,500 shares of common stock of Clene Inc for $0.01 per share. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 22:24 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 20,000 | $5.26 | $105,200.00 |
DisclosureSEC source: 0001562180-21-007119 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,423,897 F1 · ownership.direct: Mr. Matlin purchased 20,000 shares of common stock of Clene Inc. on November 16, 2021 for a purchase price of $5.26 per share. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 21:41 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 15,000 | $5.71 | $85,650.00 |
DisclosureSEC source: 0001562180-21-007047 · primarydocument.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,897 F2 · ownership.direct: Mr. Matlin purchased 15,000 shares of common stock of Clene Inc. on November 15, 2021 for a purchase price of $5.71 per share. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:41 UTC |
MATLIN DAVID JDirector
|
PurchaseCommon Stock | 10,000 | $5.37 | $53,700.00 |
DisclosureSEC source: 0001562180-21-007047 · primarydocument.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388,897 F1 · ownership.direct: Mr. Matlin purchased 10,000 shares of common stock of Clene Inc. on November 12, 2021 for a purchase price of $5.37 per share. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 22:52 UTC |
McLaughlin VallerieDirector
|
GrantStock Options (Right to buy) · Derivative | 3,188 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006852 · primarydocument.xml · derivative · entry 1 McLaughlin Vallerie · CIK 0001876030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,188 Underlying: Common Stock · 3,188 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 3,188 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 22:50 UTC |
Gay JonathonDirector
|
GrantStock Options (Right to buy) · Derivative | 3,188 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006849 · primarydocument.xml · derivative · entry 1 Gay Jonathon · CIK 0001835422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,188 Underlying: Common Stock · 3,188 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 3,188 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 18:57 UTC |
Glanzman RobertChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 100,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006854 · primarydocument.xml · derivative · entry 1 Glanzman Robert · CIK 0001835428 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 100,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 18:58 UTC |
Jeong Tae HeumChief Finance Officer
|
GrantStock Options (Right to buy) · Derivative | 62,500 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006856 · primarydocument.xml · derivative · entry 1 Jeong Tae Heum · CIK 0001317190 · Chief Finance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 62,500 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 22:51 UTC |
MATLIN DAVID JDirector
|
GrantStock Options (Right to buy) · Derivative | 5,651 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006851 · primarydocument.xml · derivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Common Stock · 5,561 shares Expires 2031-10-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 5,651 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 22:53 UTC |
Stevens John HenryDirector
|
GrantStock Options (Right to buy) · Derivative | 3,333 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006853 · primarydocument.xml · derivative · entry 1 Stevens John Henry · CIK 0001835543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common Stock · 3,333 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 3,333 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 22:58 UTC |
Etherington Robert DeeDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 100,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006855 · primarydocument.xml · derivative · entry 1 Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 100,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 22:49 UTC |
Jacobovitz ShalomDirector
|
GrantStock Options (Right to buy) · Derivative | 4,311 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006848 · primarydocument.xml · derivative · entry 1 Jacobovitz Shalom · CIK 0001835556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,311 Underlying: Common Stock · 4,311 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 4,311 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:14 UTC |
Mortenson MarkChief Science Officer
|
GrantStock Options (Right to buy) · Derivative | 200,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006878 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 200,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:16 UTC |
Ugwumba ChidozieDirector
|
GrantStock Options (Right to buy) · Derivative | 3,441 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006879 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,441 Underlying: Common Stock · 3.441 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 3,441 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 21:50 UTC |
Mosca AlisonDirector
|
GrantStock Options (Right to buy) · Derivative | 4,419 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006877 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,419 Underlying: Common Stock · 4,419 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 4,419 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| October 01, 2021 Filed Jan 20, 2022 21:39 UTC |
Mosca AlisonDirector
|
OtherWarrants (Right to buy) · Derivative | 10,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001596771-22-000001 · primary_doc.xml · derivative · entry 4 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-12-30 F2 · ownership.nature: The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary or profits interest in the securities held by the Robert C. Gay 1998 Family Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.